aluates Reports

$ 0.0

Automative

Global Predictive Presymptomatic Testing Market Research Report 2025

Published Date: June 2025

Report Code: QYRE-Auto-34C5632

Global Predictive Presymptomatic Testing Market Insights Forecast to 2028

BUY CHAPTERS

Global Predictive Presymptomatic Testing Market Research Report 2025

Code: QYRE-Auto-34C5632

Report

June 2025

Pages:73

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

23andMe

Abbott Laboratories

Bayer Healthcare AG.

Biocartis SA

BioHelix Corporation

Biomerieux

Celera Corporation (Quest Diagnostics)

Cepheid (Danaher)

Daan Diagnostics Ltd.

EKF Diagnostics Holdings plc

Predictive Presymptomatic Testing Market

The global market for Predictive Presymptomatic Testing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

North American market for Predictive Presymptomatic Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Predictive Presymptomatic Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Predictive Presymptomatic Testing in Breast and Ovarian Cancer is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Predictive Presymptomatic Testing include 23andMe, Inc., Abbott Laboratories, Bayer HealthCare AG, Biocartis SA, BioHelix Corporation, bioMerieux S.A., Celera Corporation (Quest Diagnostics), Cepheid (Danaher), Daan Diagnostics Ltd., EKF Diagnostics Holdings plc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Predictive Presymptomatic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Predictive Presymptomatic Testing.

The Predictive Presymptomatic Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Predictive Presymptomatic Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Predictive Presymptomatic Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Predictive Presymptomatic Testing Market Report

Report Metric	Details
Report Name	Predictive Presymptomatic Testing Market
Segment by Type	Molecular Testing Cytogenic Testing Biochemical Testing
Segment by Application	Breast and Ovarian Cancer Colorectal Cancer Alzheimer's Disease Multiple Endocrine Neoplasia Type 2 Haemochromatosis
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	23andMe, Inc., Abbott Laboratories, Bayer HealthCare AG, Biocartis SA, BioHelix Corporation, bioMerieux S.A., Celera Corporation (Quest Diagnostics), Cepheid (Danaher), Daan Diagnostics Ltd., EKF Diagnostics Holdings plc
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Predictive Presymptomatic Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Predictive Presymptomatic Testing Market report?

Ans: The main players in the Predictive Presymptomatic Testing Market are 23andMe, Inc., Abbott Laboratories, Bayer HealthCare AG, Biocartis SA, BioHelix Corporation, bioMerieux S.A., Celera Corporation (Quest Diagnostics), Cepheid (Danaher), Daan Diagnostics Ltd., EKF Diagnostics Holdings plc

What are the Application segmentation covered in the Predictive Presymptomatic Testing Market report?

Ans: The Applications covered in the Predictive Presymptomatic Testing Market report are Breast and Ovarian Cancer, Colorectal Cancer, Alzheimer's Disease, Multiple Endocrine Neoplasia Type 2, Haemochromatosis

What are the Type segmentation covered in the Predictive Presymptomatic Testing Market report?

Ans: The Types covered in the Predictive Presymptomatic Testing Market report are Molecular Testing, Cytogenic Testing, Biochemical Testing

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Predictive Presymptomatic Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Molecular Testing

1.2.3 Cytogenic Testing

1.2.4 Biochemical Testing

1.3 Market by Application

1.3.1 Global Predictive Presymptomatic Testing Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Breast and Ovarian Cancer

1.3.3 Colorectal Cancer

1.3.4 Alzheimer's Disease

1.3.5 Multiple Endocrine Neoplasia Type 2

1.3.6 Haemochromatosis

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Predictive Presymptomatic Testing Market Perspective (2020-2031)

2.2 Global Predictive Presymptomatic Testing Growth Trends by Region

2.2.1 Global Predictive Presymptomatic Testing Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Predictive Presymptomatic Testing Historic Market Size by Region (2020-2025)

2.2.3 Predictive Presymptomatic Testing Forecasted Market Size by Region (2026-2031)

2.3 Predictive Presymptomatic Testing Market Dynamics

2.3.1 Predictive Presymptomatic Testing Industry Trends

2.3.2 Predictive Presymptomatic Testing Market Drivers

2.3.3 Predictive Presymptomatic Testing Market Challenges

2.3.4 Predictive Presymptomatic Testing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Predictive Presymptomatic Testing Players by Revenue

3.1.1 Global Top Predictive Presymptomatic Testing Players by Revenue (2020-2025)

3.1.2 Global Predictive Presymptomatic Testing Revenue Market Share by Players (2020-2025)

3.2 Global Predictive Presymptomatic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Predictive Presymptomatic Testing Revenue

3.4 Global Predictive Presymptomatic Testing Market Concentration Ratio

3.4.1 Global Predictive Presymptomatic Testing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Predictive Presymptomatic Testing Revenue in 2024

3.5 Global Key Players of Predictive Presymptomatic Testing Head office and Area Served

3.6 Global Key Players of Predictive Presymptomatic Testing, Product and Application

3.7 Global Key Players of Predictive Presymptomatic Testing, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Predictive Presymptomatic Testing Breakdown Data by Type

4.1 Global Predictive Presymptomatic Testing Historic Market Size by Type (2020-2025)

4.2 Global Predictive Presymptomatic Testing Forecasted Market Size by Type (2026-2031)

5 Predictive Presymptomatic Testing Breakdown Data by Application

5.1 Global Predictive Presymptomatic Testing Historic Market Size by Application (2020-2025)

5.2 Global Predictive Presymptomatic Testing Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Predictive Presymptomatic Testing Market Size (2020-2031)

6.2 North America Predictive Presymptomatic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Predictive Presymptomatic Testing Market Size by Country (2020-2025)

6.4 North America Predictive Presymptomatic Testing Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Predictive Presymptomatic Testing Market Size (2020-2031)

7.2 Europe Predictive Presymptomatic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Predictive Presymptomatic Testing Market Size by Country (2020-2025)

7.4 Europe Predictive Presymptomatic Testing Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Predictive Presymptomatic Testing Market Size (2020-2031)

8.2 Asia-Pacific Predictive Presymptomatic Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Predictive Presymptomatic Testing Market Size by Region (2020-2025)

8.4 Asia-Pacific Predictive Presymptomatic Testing Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Predictive Presymptomatic Testing Market Size (2020-2031)

9.2 Latin America Predictive Presymptomatic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Predictive Presymptomatic Testing Market Size by Country (2020-2025)

9.4 Latin America Predictive Presymptomatic Testing Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Predictive Presymptomatic Testing Market Size (2020-2031)

10.2 Middle East & Africa Predictive Presymptomatic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Predictive Presymptomatic Testing Market Size by Country (2020-2025)

10.4 Middle East & Africa Predictive Presymptomatic Testing Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 23andMe, Inc.

11.1.1 23andMe, Inc. Company Details

11.1.2 23andMe, Inc. Business Overview

11.1.3 23andMe, Inc. Predictive Presymptomatic Testing Introduction

11.1.4 23andMe, Inc. Revenue in Predictive Presymptomatic Testing Business (2020-2025)

11.1.5 23andMe, Inc. Recent Development

11.2 Abbott Laboratories

11.2.1 Abbott Laboratories Company Details

11.2.2 Abbott Laboratories Business Overview

11.2.3 Abbott Laboratories Predictive Presymptomatic Testing Introduction

11.2.4 Abbott Laboratories Revenue in Predictive Presymptomatic Testing Business (2020-2025)

11.2.5 Abbott Laboratories Recent Development

11.3 Bayer HealthCare AG

11.3.1 Bayer HealthCare AG Company Details

11.3.2 Bayer HealthCare AG Business Overview

11.3.3 Bayer HealthCare AG Predictive Presymptomatic Testing Introduction

11.3.4 Bayer HealthCare AG Revenue in Predictive Presymptomatic Testing Business (2020-2025)

11.3.5 Bayer HealthCare AG Recent Development

11.4 Biocartis SA

11.4.1 Biocartis SA Company Details

11.4.2 Biocartis SA Business Overview

11.4.3 Biocartis SA Predictive Presymptomatic Testing Introduction

11.4.4 Biocartis SA Revenue in Predictive Presymptomatic Testing Business (2020-2025)

11.4.5 Biocartis SA Recent Development

11.5 BioHelix Corporation

11.5.1 BioHelix Corporation Company Details

11.5.2 BioHelix Corporation Business Overview

11.5.3 BioHelix Corporation Predictive Presymptomatic Testing Introduction

11.5.4 BioHelix Corporation Revenue in Predictive Presymptomatic Testing Business (2020-2025)

11.5.5 BioHelix Corporation Recent Development

11.6 bioMerieux S.A.

11.6.1 bioMerieux S.A. Company Details

11.6.2 bioMerieux S.A. Business Overview

11.6.3 bioMerieux S.A. Predictive Presymptomatic Testing Introduction

11.6.4 bioMerieux S.A. Revenue in Predictive Presymptomatic Testing Business (2020-2025)

11.6.5 bioMerieux S.A. Recent Development

11.7 Celera Corporation (Quest Diagnostics)

11.7.1 Celera Corporation (Quest Diagnostics) Company Details

11.7.2 Celera Corporation (Quest Diagnostics) Business Overview

11.7.3 Celera Corporation (Quest Diagnostics) Predictive Presymptomatic Testing Introduction

11.7.4 Celera Corporation (Quest Diagnostics) Revenue in Predictive Presymptomatic Testing Business (2020-2025)

11.7.5 Celera Corporation (Quest Diagnostics) Recent Development

11.8 Cepheid (Danaher)

11.8.1 Cepheid (Danaher) Company Details

11.8.2 Cepheid (Danaher) Business Overview

11.8.3 Cepheid (Danaher) Predictive Presymptomatic Testing Introduction

11.8.4 Cepheid (Danaher) Revenue in Predictive Presymptomatic Testing Business (2020-2025)

11.8.5 Cepheid (Danaher) Recent Development

11.9 Daan Diagnostics Ltd.

11.9.1 Daan Diagnostics Ltd. Company Details

11.9.2 Daan Diagnostics Ltd. Business Overview

11.9.3 Daan Diagnostics Ltd. Predictive Presymptomatic Testing Introduction

11.9.4 Daan Diagnostics Ltd. Revenue in Predictive Presymptomatic Testing Business (2020-2025)

11.9.5 Daan Diagnostics Ltd. Recent Development

11.10 EKF Diagnostics Holdings plc

11.10.1 EKF Diagnostics Holdings plc Company Details

11.10.2 EKF Diagnostics Holdings plc Business Overview

11.10.3 EKF Diagnostics Holdings plc Predictive Presymptomatic Testing Introduction

11.10.4 EKF Diagnostics Holdings plc Revenue in Predictive Presymptomatic Testing Business (2020-2025)

11.10.5 EKF Diagnostics Holdings plc Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

23andMe

Abbott Laboratories

Bayer Healthcare AG.

Biocartis SA

BioHelix Corporation

Biomerieux

Celera Corporation (Quest Diagnostics)

Cepheid (Danaher)

Daan Diagnostics Ltd.

EKF Diagnostics Holdings plc

List of Tables

Table 1. Global Predictive Presymptomatic Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Molecular Testing

Table 3. Key Players of Cytogenic Testing

Table 4. Key Players of Biochemical Testing

Table 5. Global Predictive Presymptomatic Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Predictive Presymptomatic Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Predictive Presymptomatic Testing Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Predictive Presymptomatic Testing Market Share by Region (2020-2025)

Table 9. Global Predictive Presymptomatic Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Predictive Presymptomatic Testing Market Share by Region (2026-2031)

Table 11. Predictive Presymptomatic Testing Market Trends

Table 12. Predictive Presymptomatic Testing Market Drivers

Table 13. Predictive Presymptomatic Testing Market Challenges

Table 14. Predictive Presymptomatic Testing Market Restraints

Table 15. Global Predictive Presymptomatic Testing Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Predictive Presymptomatic Testing Market Share by Players (2020-2025)

Table 17. Global Top Predictive Presymptomatic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Predictive Presymptomatic Testing as of 2024)

Table 18. Ranking of Global Top Predictive Presymptomatic Testing Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Predictive Presymptomatic Testing Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Predictive Presymptomatic Testing, Headquarters and Area Served

Table 21. Global Key Players of Predictive Presymptomatic Testing, Product and Application

Table 22. Global Key Players of Predictive Presymptomatic Testing, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Predictive Presymptomatic Testing Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Predictive Presymptomatic Testing Revenue Market Share by Type (2020-2025)

Table 26. Global Predictive Presymptomatic Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Predictive Presymptomatic Testing Revenue Market Share by Type (2026-2031)

Table 28. Global Predictive Presymptomatic Testing Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Predictive Presymptomatic Testing Revenue Market Share by Application (2020-2025)

Table 30. Global Predictive Presymptomatic Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Predictive Presymptomatic Testing Revenue Market Share by Application (2026-2031)

Table 32. North America Predictive Presymptomatic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Predictive Presymptomatic Testing Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Predictive Presymptomatic Testing Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Predictive Presymptomatic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Predictive Presymptomatic Testing Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Predictive Presymptomatic Testing Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Predictive Presymptomatic Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Predictive Presymptomatic Testing Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Predictive Presymptomatic Testing Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Predictive Presymptomatic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Predictive Presymptomatic Testing Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Predictive Presymptomatic Testing Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Predictive Presymptomatic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Predictive Presymptomatic Testing Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Predictive Presymptomatic Testing Market Size by Country (2026-2031) & (US$ Million)

Table 47. 23andMe, Inc. Company Details

Table 48. 23andMe, Inc. Business Overview

Table 49. 23andMe, Inc. Predictive Presymptomatic Testing Product

Table 50. 23andMe, Inc. Revenue in Predictive Presymptomatic Testing Business (2020-2025) & (US$ Million)

Table 51. 23andMe, Inc. Recent Development

Table 52. Abbott Laboratories Company Details

Table 53. Abbott Laboratories Business Overview

Table 54. Abbott Laboratories Predictive Presymptomatic Testing Product

Table 55. Abbott Laboratories Revenue in Predictive Presymptomatic Testing Business (2020-2025) & (US$ Million)

Table 56. Abbott Laboratories Recent Development

Table 57. Bayer HealthCare AG Company Details

Table 58. Bayer HealthCare AG Business Overview

Table 59. Bayer HealthCare AG Predictive Presymptomatic Testing Product

Table 60. Bayer HealthCare AG Revenue in Predictive Presymptomatic Testing Business (2020-2025) & (US$ Million)

Table 61. Bayer HealthCare AG Recent Development

Table 62. Biocartis SA Company Details

Table 63. Biocartis SA Business Overview

Table 64. Biocartis SA Predictive Presymptomatic Testing Product

Table 65. Biocartis SA Revenue in Predictive Presymptomatic Testing Business (2020-2025) & (US$ Million)

Table 66. Biocartis SA Recent Development

Table 67. BioHelix Corporation Company Details

Table 68. BioHelix Corporation Business Overview

Table 69. BioHelix Corporation Predictive Presymptomatic Testing Product

Table 70. BioHelix Corporation Revenue in Predictive Presymptomatic Testing Business (2020-2025) & (US$ Million)

Table 71. BioHelix Corporation Recent Development

Table 72. bioMerieux S.A. Company Details

Table 73. bioMerieux S.A. Business Overview

Table 74. bioMerieux S.A. Predictive Presymptomatic Testing Product

Table 75. bioMerieux S.A. Revenue in Predictive Presymptomatic Testing Business (2020-2025) & (US$ Million)

Table 76. bioMerieux S.A. Recent Development

Table 77. Celera Corporation (Quest Diagnostics) Company Details

Table 78. Celera Corporation (Quest Diagnostics) Business Overview

Table 79. Celera Corporation (Quest Diagnostics) Predictive Presymptomatic Testing Product

Table 80. Celera Corporation (Quest Diagnostics) Revenue in Predictive Presymptomatic Testing Business (2020-2025) & (US$ Million)

Table 81. Celera Corporation (Quest Diagnostics) Recent Development

Table 82. Cepheid (Danaher) Company Details

Table 83. Cepheid (Danaher) Business Overview

Table 84. Cepheid (Danaher) Predictive Presymptomatic Testing Product

Table 85. Cepheid (Danaher) Revenue in Predictive Presymptomatic Testing Business (2020-2025) & (US$ Million)

Table 86. Cepheid (Danaher) Recent Development

Table 87. Daan Diagnostics Ltd. Company Details

Table 88. Daan Diagnostics Ltd. Business Overview

Table 89. Daan Diagnostics Ltd. Predictive Presymptomatic Testing Product

Table 90. Daan Diagnostics Ltd. Revenue in Predictive Presymptomatic Testing Business (2020-2025) & (US$ Million)

Table 91. Daan Diagnostics Ltd. Recent Development

Table 92. EKF Diagnostics Holdings plc Company Details

Table 93. EKF Diagnostics Holdings plc Business Overview

Table 94. EKF Diagnostics Holdings plc Predictive Presymptomatic Testing Product

Table 95. EKF Diagnostics Holdings plc Revenue in Predictive Presymptomatic Testing Business (2020-2025) & (US$ Million)

Table 96. EKF Diagnostics Holdings plc Recent Development

Table 97. Research Programs/Design for This Report

Table 98. Key Data Information from Secondary Sources

Table 99. Key Data Information from Primary Sources

Table 100. Authors List of This Report

List of Figures

Figure 1. Predictive Presymptomatic Testing Picture

Figure 2. Global Predictive Presymptomatic Testing Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Predictive Presymptomatic Testing Market Share by Type: 2024 VS 2031

Figure 4. Molecular Testing Features

Figure 5. Cytogenic Testing Features

Figure 6. Biochemical Testing Features

Figure 7. Global Predictive Presymptomatic Testing Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Predictive Presymptomatic Testing Market Share by Application: 2024 VS 2031

Figure 9. Breast and Ovarian Cancer Case Studies

Figure 10. Colorectal Cancer Case Studies

Figure 11. Alzheimer's Disease Case Studies

Figure 12. Multiple Endocrine Neoplasia Type 2 Case Studies

Figure 13. Haemochromatosis Case Studies

Figure 14. Predictive Presymptomatic Testing Report Years Considered

Figure 15. Global Predictive Presymptomatic Testing Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Predictive Presymptomatic Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Predictive Presymptomatic Testing Market Share by Region: 2024 VS 2031

Figure 18. Global Predictive Presymptomatic Testing Market Share by Players in 2024

Figure 19. Global Top Predictive Presymptomatic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Predictive Presymptomatic Testing as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Predictive Presymptomatic Testing Revenue in 2024

Figure 21. North America Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Predictive Presymptomatic Testing Market Share by Country (2020-2031)

Figure 23. United States Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Predictive Presymptomatic Testing Market Share by Country (2020-2031)

Figure 27. Germany Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Predictive Presymptomatic Testing Market Share by Region (2020-2031)

Figure 35. China Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Predictive Presymptomatic Testing Market Share by Country (2020-2031)

Figure 43. Mexico Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Predictive Presymptomatic Testing Market Share by Country (2020-2031)

Figure 47. Turkey Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. 23andMe, Inc. Revenue Growth Rate in Predictive Presymptomatic Testing Business (2020-2025)

Figure 51. Abbott Laboratories Revenue Growth Rate in Predictive Presymptomatic Testing Business (2020-2025)

Figure 52. Bayer HealthCare AG Revenue Growth Rate in Predictive Presymptomatic Testing Business (2020-2025)

Figure 53. Biocartis SA Revenue Growth Rate in Predictive Presymptomatic Testing Business (2020-2025)

Figure 54. BioHelix Corporation Revenue Growth Rate in Predictive Presymptomatic Testing Business (2020-2025)

Figure 55. bioMerieux S.A. Revenue Growth Rate in Predictive Presymptomatic Testing Business (2020-2025)

Figure 56. Celera Corporation (Quest Diagnostics) Revenue Growth Rate in Predictive Presymptomatic Testing Business (2020-2025)

Figure 57. Cepheid (Danaher) Revenue Growth Rate in Predictive Presymptomatic Testing Business (2020-2025)

Figure 58. Daan Diagnostics Ltd. Revenue Growth Rate in Predictive Presymptomatic Testing Business (2020-2025)

Figure 59. EKF Diagnostics Holdings plc Revenue Growth Rate in Predictive Presymptomatic Testing Business (2020-2025)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global PRE Employment Testing Market Research Report 2024

Global Preclinical Testing Service Market Research Report 2025

Global Predictive Genetic Testing And Consumer Genomics Market Research Report 2024

Global Pre Silicon Testing Solutions Market Research Report 2025

Global Pre Pregnancy Genetic Testing Market Research Report 2024

Global Breast Cancer Predictive Genetic Testing Market Research Report 2024

Global Pre Employment Assessment Testing Software Market Research Report 2025

Prescriptive and Predictive Analytics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Mental Health Tester Market Research Report 2024

Global Predisposition Biomarkers Market Research Report 2024

Global Regression Testing Tool Market Research Report 2025

Global Predictive Analytics Platform Market Research Report 2025

Global Predictive Genetic Testing and Genomics Market Research Report 2025

Global Testing Machines Market Research Report 2024

Global Cleanliness Testing Market Research Report 2025

Global Precancer Molecular Diagnostics Market Research Report 2024

Global Sleep Test Market Research Report 2025

Global Lab Development Testing Market Research Report 2024

Global Cleanroom Testing Market Research Report 2024

RELATED REPORTS

Global BPO in Public Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-17F6185

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Ultra-Thin Thermal Management Transfer Tape Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-15E19879

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stencil Printer for Semiconductor Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29C17006

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gamification in Sports Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-4X18374

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions